c-erbB-2 oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix
- 1 February 1994
- Vol. 73 (3) , 668-671
- https://doi.org/10.1002/1097-0142(19940201)73:3<668::aid-cncr2820730327>3.0.co;2-d
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Prognostic significance of the PC10 index as a prospective assay for cervical cancer treated with radiation therapy aloneCancer, 1992
- Prognostic value of c-erbB-2 expression in uterine cervical carcinoma.Journal of Clinical Pathology, 1992
- High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. A 20-year experienceCancer, 1992
- An evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short-term prognosis in breast cancerBritish Journal of Cancer, 1989
- Neu-Protein Overexpression in Breast CancerNew England Journal of Medicine, 1988
- Amplification of c-erbB-2 and Aggressive Human Breast Tumors?Science, 1988
- C-myc PROTO-ONCOGENE EXPRESSION AND PROGNOSIS IN EARLY CARCINOMA OF THE UTERINE CERVIXThe Lancet, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958